Activity in this selectionUnited States · Mar 31, 2026 · Mar 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $10M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionRyboDynDecodes the dark proteome using an AI-powered novel sequencing and discovery platform to reveal novel cancer targets
Role not disclosed